Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Eupraxia Pharmaceuticals Inc banner

Eupraxia Pharmaceuticals Inc
NASDAQ:EPRX

Watchlist Manager
Eupraxia Pharmaceuticals Inc Logo
Eupraxia Pharmaceuticals Inc
NASDAQ:EPRX
Watchlist
Price: 8.38 USD 3.58% Market Closed
Market Cap: $298.5m
Write Note Create Alert Ask AI

Wall St Price Targets

EPRX Price Targets Summary
Eupraxia Pharmaceuticals Inc

Wall Street analysts forecast EPRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EPRX is 11.75 USD with a low forecast of 10.18 USD and a high forecast of 15.97 USD.

EPRX Lowest Forecast
Wall Street Target
$10.18
22% Upside
EPRX Average Forecast
Wall Street Target
$11.75
40% Upside
EPRX Highest Forecast
Wall Street Target
$15.97
91% Upside
Lowest Forecast
Price Target
10.18 USD
22% Upside
Average Forecast
Price Target
11.75 USD
40% Upside
Highest Forecast
Price Target
15.97 USD
91% Upside
Eupraxia Pharmaceuticals Inc Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Eupraxia Pharmaceuticals Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat

What are analyst estimates?

Continue EPRX Research

Summary
EPRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
EPRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EPRX stock valuation using valuation multiples.
Wall St Estimates
EPRX price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EPRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Eupraxia Pharmaceuticals Inc listings:
TSX • CAD
EPRX
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EPRX's stock price target?
Price Target
11.75 USD

According to Wall Street analysts, the average 1-year price target for EPRX is 11.75 USD with a low forecast of 10.18 USD and a high forecast of 15.97 USD.

Back to Top
ALPHA SPREAD
Follow us
Join 358,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.